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Epidemiologic studies have observed associa-
tions between short-term increases in ambient
particle concentrations and increases in respira-
tory and cardiovascular morbidity and mortal-
ity rates (1). Prospective cohort studies suggest
that people with preexisting cardiopulmonary
disease are more susceptible to the effects of
urban ambient particles (2). Chronic obstruc-
tive pulmonary disease (COPD) is consis-
tently associated with increased relative risk of
death in relationship to ambient particulate air
pollution (3).
Inhalation exposure of rodents to high lev-
els of sulfur dioxide has provided an animal
model similar to human COPD (4–7).
Recently, this rat model of chronic bronchitis
(CB) was used to study the effects of inhaled
ambient particles (8,9) using the Harvard
Ambient Particle Concentrator (HAPC). This
device concentrates ambient outdoor particles
in the fine particle range (0.1–2.5 µm) for
subsequent direct delivery for animal exposure
(10,11). These studies demonstrated that con-
centrated ambient particles (CAPs) induced
changes in pulmonary breathing parameters
and elicited variable degrees of pulmonary
inﬂammation (8,9).
In animal studies, deaths associated with
particle exposures have been observed in stud-
ies using a rat model of pulmonary vascular
injury induced by monocrotaline (12–17),
whereas deaths were rarely observed in studies
of animals with CB (18). Signiﬁcant mortality
was observed in the models of monocrotaline-
induced pulmonary vascular injury after
inhalation (13) or intratracheal instillation
(12,14–16) of residual oil ﬂy ash (ROFA) par-
ticles. Deaths associated with CAPs inhalation
exposures have also been reported for the
monocrotaline model (17). Additionally,
spontaneously hypertensive rats have underly-
ing pulmonary vascular disease (19) and
exhibit a greater susceptibility to adverse
health effects from inhaled (20) or intratra-
cheally instilled ROFA (21).
Other studies also indicate a potentially
important interaction between the inhalation
of particles and pulmonary vascular injury.
Short-term exposure of Sprague-Dawley rats
to cigarette smoke produced pathologic fea-
tures typical of pulmonary hypertension,
including proliferation of cells in the
endothelium and walls of the pulmonary
artery (22). Moreover, in a guinea pig model
of cigarette smoke-induced emphysema, the
progression of histologic changes of pul-
monary hypertension were greater than and
dissociated from emphysema progression
(23). The pulmonary vascular framework is
target and host to a variety of reactions to
xenobiotic exposure and injury (24). Its close
anatomical and functional proximity to the
surface of the respiratory tract enhances its
potential as a target for components of inhaled
urban ambient particles. Our histomorpho-
metric study focused on the small branches of
pulmonary arteries adjacent to the bron-
choalveolar junction of rats exposed to CAPs.
Substantial concentrations of bioavailable
compounds may be released from deposited
ambient particles in this tissue region because
this is the site of highest deposition (25–28).
The aim of this study was to assess the
morphology of the pulmonary arterial vascu-
lature in normal and CB rats and to deter-
mine whether short-term inhalation of CAPs
produced any alterations measured morpho-
metrically. Linear regression analysis was used
to identify specific components of CAPs
exposure associated with the measured change
in vascular responses.
Materials and Methods
Experimental groups and exposure protocol.
Male Sprague-Dawley rats (200–250 g)
were obtained from Harlan Laboratories
(Indianapolis, IN, USA) and were managed
in accordance with the National Institutes
of Health guidelines for care and storage of
laboratory animals (29). 
The model of CB was developed by expos-
ing the rats to a target concentration of 250
ppm of sulfur dioxide (5 hr/day, 5 days/week
for 6 weeks), as previously described (5,6,8).
Briefly, SO2 of known concentration was
obtained from a cylinder, diluted with air, and
fed into the exposure chamber at a constant
rate (7.6 ft3/min). The concentration of SO2 in
the chamber was monitored continuously by
an automatic flame photometric sulfur ana-
lyzer system (Meloy Labs, Inc., Springfield,
VA, USA). For this purpose, a sample from
the chamber was diluted 1:1,000 with room
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Articles
The objective of this study was to determine whether short-term exposures to concentrated ambi-
ent particles (CAPs) alter the morphology of small pulmonary arteries in normal rats and rats with
chronic bronchitis (CB). Sprague-Dawley male rats were exposed to CAPs, using the Harvard
Ambient Particle Concentrator, or to particle-free air (sham) under identical conditions during 3
consecutive days (5 hr/day) in six experimental sets. CB was induced by exposure to 276 ± 9 ppm
of sulfur dioxide (5 hr/day, 5 days/week, 6 weeks). Physicochemical characterization of CAPs
included measurements of particle mass, size distribution, and composition. Rats were sacriﬁced
24 hr after the last CAPs exposure. Histologic slides were prepared from random sections of lung
lobes and coded for blinded analysis. The lumen/wall area (L/W) ratio was determined morpho-
metrically on transverse sections of small pulmonary arteries. When all animal data (normal and
CB) were analyzed together, the L/W ratios decreased as concentrations of ﬁne particle mass, sili-
con, lead, sulfate, elemental carbon, and organic carbon increased. In separate univariate analyses
of animal data, the association for sulfate was signiﬁcant only in normal rats, whereas silicon was
signiﬁcantly associated in both CB and normal rats. In multivariate analyses including all particle
factors, the association with silicon remained significant. Our results indicate that short-term
CAPs exposures (median, 182.75 µg/m3; range, 73.50–733.00 µg/m3) can induce vasoconstriction
of small pulmonary arteries in normal and CB rats. This effect was correlated with speciﬁc particle
components and suggests that the pulmonary vasculature might be an important target for ambi-
ent air particle toxicity. Key words: ambient particles, endothelial injury, pulmonary artery, rats,
vasoconstriction. Environ Health Perspect 110:1191–1197 (2002). [Online 30 September 2002]
http://ehpnet1.niehs.nih.gov/docs/2002/110p1191-1197batalha/abstract.htmlair and fed into the analyzer. The sulfur analy-
sis was calibrated using an SO2 permeation-
tube calibration source (Meloy Labs). The
average SO2 concentration for all experiments
was 276.4 ± 9.1 ppm. Normal control animals
were maintained in the same conditions but
were exposed to SO2-free ﬁltered air. For each
experiment, CB and normal control rats were
exposed to either CAPs or ﬁltered air in sham
conditions for 5 hr/day for 3 consecutive days. 
Sham or CAPs exposures were adminis-
tered in six different experiments, conducted
in different seasons, allowing variations in
ambient particle concentrations and composi-
tion. Table 1 outlines the experimental expo-
sure design protocol, the numbers of animals
per group, and the average exposure concentra-
tion. Four experimental groups were studied:
a) 13 normal control rats exposed to ﬁltered air
(normal/sham); b) 15 normal control rats
exposed to CAPs (normal/CAPs); c) 13 CB
rats exposed to filtered air (CB/sham); and
d) 15 CB rats exposed to CAPs (CB/CAPs).
Animal exposures were performed using
the HAPC as previously described (8,10,11).
Continuous measurements of CAPs mass con-
centrations were conducted using a tapered
element oscillating microbalance (30). Black
carbon concentrations were measured using
an aethalometer (model AE-14; Magee
Scientiﬁc Inc., Berkeley, CA, USA) (31). The
integrated ambient and chamber concentra-
tions of particulate mass were determined
gravimetrically. Particles were collected on
preweighed 47-mm Teflon filters (P/N
R2PJ047; Pall Corporation, Ann Arbor, MI)
with a collection ﬂow rate of 3 L/min. Filters
were weighed using a Mettler MT-5 microbal-
ance (Mettler Toledo, Columbus, OH) in a
temperature- and humidity-controlled room.
Sampling ﬂow rate, sampling time, and ﬁlter
weight were used to calculate the particle con-
centration (micrograms per cubic meter).
Concentrated particles were also collected
on Teﬂon ﬁlters for measurement of sulfate,
elemental carbon (EC), organic carbon (OC),
and elemental analysis. Sulfate concentrations
were determined using ion chromatography
(32). EC and OC measurements were con-
ducted by a thermal and optical reflectance
method (33). Elemental analyses were per-
formed by X-ray ﬂuorescence (34). To char-
acterize the size distribution of ambient
particles, samples were collected isokinetically
from the concentrator inlet using a micro-
orifice uniform deposit impactor (MOUDI;
MSP Corporation, Minneapolis, MN, USA)
as previously described (35).
Histopathology and morphometry.The
rats were euthanized using an overdose of
sodium pentobarbital 24 hr after the last day
(third day) of exposure. The lungs were
excised and ﬁxed by intratracheal instillation
of 2.5% glutaraldehyde in 0.1 M potassium
phosphate buffer at constant pressure of 20
cm H2O. After ﬁxation, all lung lobes (except
for the cardiac lobe) were cut horizontally
into uniform 2-mm sections with a guided
razor blade. Each section was numbered, and
one randomly selected section from each lobe
was processed for histology. Tissue samples
were embedded in paraffin, sectioned at 5
µm, and stained with hematoxylin and eosin
for analysis by light microscopy. Histologic
slides were coded for blinded analysis, and the
observer was unaware of the code until the
analysis was completed.
For morphometric assessment, each slide
was ﬁrst viewed at low magniﬁcation to select
arteries meeting speciﬁc criteria for measure-
ment: a) each artery was adjacent to bron-
choalveolar junctions (Figures 1 and 2), so that
all vessels studied were in the same size range;
and b) each artery was in true cross-section
(i.e., there was a variation of < 10% between
its maximum and minimum diameter) indicat-
ing that a transverse histologic section was
achieved. In general, each slide contained 2 or
3 arteries meeting these criteria. Thus, we
quantiﬁed 8–12 arteries per rat. 
After identifying these vessels, the ratio
between the lumen and wall areas (L/W) of
transverse sections of pulmonary arteries at the
bronchoalveolar junction was determined mor-
phometrically using a point grid (100 points)
attached to the eyepiece. Brieﬂy, at high mag-
niﬁcation (600–960×), the artery was placed in
the center of the grid, which covered the entire
Table 1. Experimental inhalation exposure design.
No. of No. of animals per group 3-day mean CAPs mass
Date animals Normal/sham Normal/CAPs CB/sham CB/CAPs concencentration (µg/m3)
March 1997 8 2 2 2 2 170.7
June 1997 8 2 2 2 2 481.0
September 1997 8 2 2 2 2 187.1
January 1998 13 3 4 3 3 126.1
February 1998 9 2 2 2 3 267.3
June 1998 10 2 3 2 3 300.7
Total 56 13 15 13 15
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Figure 1. Morphologic appearance of lung tissue in selected areas illustrating
the location of morphometric measurements, the size of the vessels studied,
and the responses of normal rats to sham or CAPs exposure. (A) In
normal/sham rats, the bronchoalveolar junction area has normal histology. (B)
In the normal/CAPs rats, epithelial hyperplasia and arterial wall changes are
visible. Note the normal pattern (arrows in A) and the thicker vessel wall
(arrows in B) of small pulmonary arteries in the transverse section near the
bronchoalveolar junctions. Scale bar = 50 µm for both A and B.
Figure 2. Morphologic appearance of lung tissue in selected areas illustrating
the location of morphometric measurements, the size of the vessels studied,
and the responses of CB rats to sham or CAPs exposure. (A) The bronchoalve-
olar junction area has airway epithelial hyperplasia and slight thickening of
the vessel wall in CB/sham rats. (B) More prominent epithelial hyperplasia and
vascular changes are present in CB/CAPs rats. Note an increased thickness
in the vessel walls (arrows) in A and even thicker vessel walls (arrows ) in the
transversely sectioned small pulmonary arteries adjacent to the broncho-
alveolar junctions in B. Scale bar = 50 µm for both A and B.vessel at the magnification used. The points
overlying the artery lumen and the points over-
lying the muscular wall were counted sepa-
rately using an unbiased counting procedure as
described previously (36). The concept of the
L/W ratio is based on mechanisms by which
vessels can narrow: a) muscular hypertrophy,
resulting in increased thickness of the wall; b)
constriction of the vessel, resulting in slight
increases in wall thickness and diminished
luminal caliber; and c) both of these events.
Classically, measurements of pulmonary
hypertension are described morphometrically
in terms of measurements of medial thickness,
which are used when hypertrophy is expected
to dominate the pathologic process [reviewed
by Wagenvoort and Wagenvoort (37)].
Because 3 days of CAPs exposure may not
elicit signiﬁcant hypertrophy (but may cause
constriction), we employed a morphometric
approach that could detect changes due to any
of the mechanisms of arterial narrowing.
Statistical analysis. We calculated descrip-
tive statistics for CAPs mass, composition, and
vascular morphometric data. For the regression
analyses, the L/W ratios were log-transformed
to satisfy model assumptions of normality and
homoscedastic variance. Three analyses of
increasing sensitivity were used to detect effects
of CAPs, CB status, and their interactions.
First, we used analysis of variance (ANOVA)
techniques to assess differences due to these
three effects while treating CAPs as a binary
exposure variable. Second, to assess the impact
of particle mass and composition, we con-
ducted univariate analyses regressing log L/W
on differential exposure concentrations using
animals of all groups as well as stratifying by
CB status. Finally, a multivariate analysis using
tracer elements of previously deﬁned pollution
sources (38) as predictors was ﬁtted to the data
to conﬁrm the univariate analyses. A principal
components analysis with varimax rotation was
conducted on the elemental data to conﬁrm the
ability of these tracer elements to represent the
intended sources in the present experiment.
In both the ANOVA and linear regres-
sion models, experiment indicators were
included as random effects in the model to
account for unexplained experiment-to-exper-
iment heterogeneity because other studies on
these animals have demonstrated additional
experiment-to-experiment variability unex-
plained by difference in exposure (39). This
unexplained heterogeneity was negligible in
this set of six experiments.
The particle parameters used in the uni-
variate analyses included mass, EC, OC, sul-
fate, silicon, vanadium, and lead. This
selection was based on the factor analysis
results of the entire data set. The selected par-
ticle parameters were highly correlated with
the identiﬁed factors, which usually represent
a particle source(s). In previous studies, we
have applied factor analysis to Boston CAPs
data in an effort to identify and quantify parti-
cle sources (38). For comparability across bio-
logic responses and elemental concentrations,
results from the mixed regression models are
reported as standardized regression coefﬁcients
(40). These quantities represent the change in
standardized response for one unit standard
deviation change in concentration. Statistical
signiﬁcance for all models was based on α =
0.05. All statistical modeling was performed
using SAS software (41). The mixed ANOVA
and linear regression models were ﬁtted using
PROC MIXED (SAS Institute, Cary, NC,
USA), whereas the factor analysis of the ele-
mental concentrations was performed using
PROC FACTOR (SAS Institute). Graphical
diagnostics of model adequacy were carried
out using the S-Plus statistical package
(Mathsoft, Inc., Seattle, WA, USA) (42).
Results
Exposure data. Fine particle mass, sulfate, EC,
OC, and elemental concentration medians,
means, standard deviations, and ranges for all
six experiments are presented in Table 2.
Concentrated ﬁne particle mass showed con-
siderable variation in concentration (range =
73.5–733.0 µg/m3). Particle composition,
which was analyzed for 16 of 18 exposure
days, also exhibited substantial variability.
Table 3 shows the results of the factor analysis
of the particle composition data. The factor
loadings are reported for each of the four
identified factors. The loadings, which were
statistically signiﬁcant, deﬁne each factor. The
mean particle size (geometric standard devia-
tion) for all experimental days was 0.27 µm
(2.3). Temperature and relative humidity
(mean ± SD) in the exposure chamber for all
experiments days were 28.3 ± 1.6°C and 45.6
± 6.6% for sham exposures and 28.9 ± 1.5°C
and 47.7 ± 7.3% for CAPs exposures.
Animal responses to exposure. Animals
exhibited no signs of irritant inhalation or dis-
comfort during exposure to either CAPs or ﬁl-
tered air. Animals mostly slept or rested quietly
throughout the exposure sets. No animal died
during any of the exposure days in any group.
Histopathology. Figure 1A illustrates the
normal morphology of the bronchoalveolar
region of the lung of normal/sham rats show-
ing terminal airways (terminal bronchiole and
alveolar duct) and cross-sectional profiles of
the adjacent small pulmonary arteries typical of
those that were used for analyses in these stud-
ies. In the normal/CAPs-exposed rats, there
was minimal thickening of the walls of small
pulmonary arteries and edema in the adventitia
(Figure 1B). Morphometric measurements
considered only the thickness of the muscular
walls of the arteries and their lumen caliber.
Perivascular edema was not included in the
morphometric measurements. Minimal hyper-
plasia of the epithelium lining the terminal
bronchiole and alveolar ducts was also present.
In comparison with the normal/sham rats, the
arterial walls of CB/sham (Figure 2A) and
CB/CAPs (Figure 2B) rats were also thickened.
Hyperplasia of the epithelium lining the termi-
nal bronchiole and alveolar ducts was also evi-
dent and was slightly more pronounced in
CAPs-exposed rats; however, the epithelial dif-
ference was not quantiﬁed morphometrically.
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Table 2. Measured ﬁne particle mass, sulfate, EC, OC, and element concentrations in the exposure cham-
ber (µg/m3) for all exposure days.
Median Mean SD Range
Mass 182.75 262.21 213.79 73.50–733.00
Sulfate 51.45 66.09 48.93 16.50–168.60
EC 8.05 11.45 8.27 2.40–29.71
OC 41.24 57.73 51.01 9.10–178.06
Aluminum 0.56 1.22 1.70 0.05–5.79
Silicon 3.37 4.62 4.33 0.64–13.95
Sulfur 22.01 25.61 16.59 6.26–55.58
Chlorine 0.00 0.68 1.33 1.21–4.05
Potassium 0.99 1.68 1.46 0.38–4.87
Calcium 1.19 1.82 1.73 0.26–6.00
Titanium 0.13 0.20 0.18 0.06–0.64
Vanadium 0.03 0.05 0.07 0.00–0.26
Chromium 0.01 0.01 0.01 0.00–0.03
Manganese 0.06 0.09 0.08 0.02–0.30
Iron 2.60 3.47 2.83 0.96–10.96
Nickel 0.04 0.05 0.04 0.01–0.16
Copper 0.09 0.10 0.05 0.04–0.23
Zinc 0.22 0.26 0.17 0.07–0.69
Arsenic 0.01 0.01 0.02 0.01–0.06
Selenium 0.01 0.02 0.03 0.00–0.14
Bromine 0.06 0.07 0.05 0.03–0.21
Cadmium 0.01 0.02 0.02 0.00–0.06
Barium 0.73 0.73 0.26 0.34–1.31
Lead 0.11 0.12 0.06 0.04–0.28
Data are same as in Saldiva et al. (39) and Godleski et al. (70). Reprinted from Godleski et al. (70) with permission from the
British Occupational Hygiene Society.Morphometry. Figure 3 shows box plots of
the pulmonary artery L/W ratios for the four
exposure groups. The medians for the four
treatment groups were 2.41 for normal/sham;
1.63 for normal/CAPs; 1.66 for CB/sham;
and 1.58 for CB/CAPs. The normal/sham
group was signiﬁcantly different (p = 0.022)
from the other groups. When CAPs exposure
was treated as a binary exposure variable, the
data did not provide strong evidence of a
change in the L/W ratio for either the normal
(p = 0.125) or the CB (p = 0.382) rats exposed
to CAPs. However, for the CAPs-exposed ani-
mals, the L/W ratio was significantly associ-
ated with particle mass and composition.
Univariate analyses were performed inde-
pendently, with biologic outcome data com-
pared with exposure data for each exposure
day, followed by combinations of days.
Exposure measurements for the ﬁrst day had
no signiﬁcant associations, and all 3 days had
trends similar to the data presented below.
There were essentially no differences between
using the second day, third day, or the mean
of the second and third days (data not
shown). Thus, all data presented here are from
the mean concentrations for all airborne mea-
surements from the second and third days of
exposure. 
The results of the individual regression
analyses of L/W ratio in relationship to parti-
cle mass concentration as well as the represen-
tative particle concentrations of components
vanadium, silicon, lead, sulfate, EC, and OC
are shown in Table 4, which presents the
regression analysis results for the total group
(normal plus CB animals) and for the normal
and CB groups individually. The sham group
is included with zero concentration in each
regression. Standardized correlation coefﬁcient
estimates, standard errors, and p-values are
included. Particle mass exhibited a signiﬁcant
association with decreasing L/W ratio for the
total group. Silicon, lead, sulfate, EC, and OC
were also signiﬁcantly associated with decreas-
ing L/W in the total group. Both sulfate and
silicon were significantly associated with
decreasing L/W ratio in the normal group.
Silicon was signiﬁcantly associated in the CB
group (p < 0.05), as was OC (p = 0.05). No
associations were found between vanadium
concentrations and L/W for any of the three
groups (total, normal, or CB). Lead was asso-
ciated in the total group, but not in either
individual group. The signiﬁcant associations
between decreasing L/W ratios and specific
particle component concentrations in Table 4
indicate a dose–response relationship. 
Figure 4 illustrates the dose–response rela-
tionship between the log L/W ratios and the
average silicon concentration for both normal
and CB rats for each experiment: log L/W
decreases linearly with increases in silicon
concentrations, which agrees with the results
presented in Table 4. To further explore the
relationship between L/W ratio and particle
mass and composition, a multivariate analysis
was conducted using normal and CB animals
and silicon, sulfate, vanadium, and lead con-
centrations as particle parameters. The results
of this analysis showed that only the associa-
tion with silicon remained signiﬁcant (coefﬁ-
cient = –0.146; p = 0.016).
Discussion
Our data suggest that the magnitude of the
observed vasoconstrictive response to CAPs
exposure is related to CAPs mass and speciﬁc
particle constituent concentrations. On the
basis of univariate regression analysis, we
found a significant decrease of pulmonary
arterial vascular L/W ratio in all rats, which
was associated with silicon, sulfate, lead, EC,
and OC components of CAPs. Considered
separately, the CB group showed significant
decreases in L/W ratio in relationship to sili-
con and OC concentrations. The normal rats
showed signiﬁcant decreases in relationship to
the sulfate and silicon concentrations. Silicon
showed the most significant association
observed when the two groups were com-
bined in the analysis. Furthermore, a multi-
variate analysis applied on the entire group
showed that only the association with silicon
remained signiﬁcant.
In recent studies conducted in our labora-
tory, dogs exposed to CAPs by inhalation also
exhibited signiﬁcant pulmonary inﬂammatory
and hematologic responses to specific con-
stituents of particles (38). Increased bron-
choalveolar-lavage neutrophil percentage, total
peripheral white blood cell counts, circulating
neutrophils, and circulating lymphocytes were
associated with increases in a factor associated
with silicon. As noted above, the concentra-
tions of silicon had the strongest associations
with decreasing L/W ratio in this study
reported here. It is known that the active gen-
eration of oxygen radicals on silica particle sur-
faces may lead to increased generation of
reactive oxygen species by cells and production
of proinflammatory mediators [reviewed by
Devlin et al. (43)], but it is not clear whether
oxygen radicals play a role in our findings.
Usually, crustal elements as amorphous silicon
dioxide and silicates cause no serious lung dis-
ease except at very high, occupational concen-
trations for a longer time than observed in
CAPs exposures of our study (44,45).
The origin of silicon in CAPs is likely to be
complex. Silicon concentrations were highly
correlated with those of other crustal elements
such as aluminum and calcium, suggesting
that silicon originates from the resuspension of
soil dust. Soil particles are present in coarse air-
borne particles (2.5–10 µm in diameter) and
are usually of local origin because of their
inability to travel over long distances (46). The
HAPC concentrates particles < 2.5 µm in
diameter; therefore, one should expect CAPs
not to contain soil particles (11). However, a
fraction of soil particles are < 2.5 µm in diame-
ter (which is commonly called the tail of the
coarse mode) and can be concentrated.
Furthermore, results from our previous CAPs
factor analysis/source apportionment studies
have shown that silicon represents 20–30% of
the mass of the silicon-related factor (38). This
percentage is similar to that measured in typi-
cal particles of terrestrial origin (46). 
Considering that we concentrate particles
in an urban environment and that our facility
is located about 75 m from a city street, it is
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Table 3. Rotating factor analysis loadings of elemental composition from CAP samples (16 days of
measurements).
Element Factor 1 Factor 2 Factor 3 Factor 4
Vanadium 0.92858* –0.08343 0.15691 0.18755
Nickel 0.92105* –0.11394 –0.02121 –0.09134
Sulfur 0.02792 0.04290 0.15738 0.96794*
Aluminum –0.00624 0.86625* 0.36702 0.02827
Silicon –0.05729 0.88280* 0.06672 0.14691
Calcium 0.03489 0.84080* 0.43334 0.13444
Bromine 0.10149 0.20709 0.92071* 0.19574
OC 0.78321* 0.23076 0.46400 0.32122
EC 0.63524 0.25281 0.46245 0.49525
Lead 0.21533 0.42040 0.77201* 0.36184
Data are the same as in Godleski et al. (70), reprinted with permission from the British Occupational Hygiene Society.
*Signiﬁcant associations deﬁning the factor. 
Figure 3. Box plot representing the distribution of
the pulmonary artery L/W ratio measurements for
the four exposure groups. 
*The normal/sham group is signiﬁcantly different from the
other three groups (p = 0.022).
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*possible that CAPs include road dust particles
in addition to others that are more directly
associated with emission from combustion
sources. Although nontoxic silicon and alu-
minum oxides represent a large fraction of the
urban road dust, these particles have been
continuously enriched with combustion-
derived material, organic semivolatile com-
pounds, and acidic inorganic gases (47). In
addition, debris from cars, such as tire- and
brake-derived particles, can constitute a large
fraction of road dust; pollen and other
bioaerosols can also be abundant in road dust
(48). Therefore, although silicon concentra-
tions as representative of pure soil particles
are not expected to induce adverse effects, it is
conceivable that silicon is a surrogate of road
dust that encompasses a large number of
components that may be responsible for the
observed effects reported in this present study
as well as our previous investigations. In
future studies, we plan to use single particle
analysis to investigate the size and composi-
tion of the silicon-related particles. Our
results support an association between L/W
ratio and OC, which is weakly correlated
with silicon, as shown in Table 3. Road dust
particles, rich in OC, may induce the
observed effects. Therefore, a better character-
ization of particle physicochemical properties
using single particle analysis will be very
important for our studies.
In the dog study (38), increased circulat-
ing neutrophils and increased bronchoalveo-
lar lavage macrophages were also associated
with the vanadium and nickel factor, which
was not associated with the vascular L/W
changes in this rat study. Signiﬁcant decreases
in red blood cell counts and hemoglobin lev-
els of dogs were correlated with the sulfur fac-
tor, which also had a significant effect on
decreasing vascular L/W ratio in our study.
Both the dog and rat studies show specific
components of ambient air particles to be
more important than mass in the develop-
ment of biologic responses.
In the same rats used for the analyses
reported here, studies focusing on lung
inflammation showed a significant increase
in bronchoalveolar lavage neutrophils and
neutrophils in the lung parenchyma with
CAPs exposure (39). CAPs compositional
analyses demonstrated a signiﬁcant and dose-
dependent association in the last 2 days of
exposure between bronchoalveolar lavage
neutrophils and tissue neutrophil density
with vanadium, bromine, and lead concen-
trations. Bronchoalveolar lavage neutrophils
and protein concentrations were also signiﬁ-
cantly associated with increases in concentra-
tions of lead, sulfate, silicon, OC, and EC,
which all were associated with decreasing
L/W ratio in our study.
A noteworthy finding of these studies is
the observed association of biologic responses
and individual particle composition, suggest-
ing that the bioavailability and activity of some
ambient particles components in speciﬁc sites
may play a fundamental role in the pathogenic
events. Despite the observed correlations, it is
not possible to identify whether the observed
changes are due to isolated or synergistic effects
among the particle components. Urban
aerosols represent a complex mixture of
anthropogenic and naturally occurring air-
borne particles either emitted directly by pollu-
tion sources, generated by reactions that occur
in the atmosphere, or produced by mechanical
resuspension (46). We used urban Boston out-
door air typically composed of particles gener-
ated by vehicle exhaust, power plant emissions,
home heating, and transported aerosols
(49,50). There was substantial variability in
exposure data in these studies. Variation in
particle mass and elemental concentrations is
related to emissions, weather, air mass trajecto-
ries, wind directions, and season. Nevertheless,
the variability in both exposure data and bio-
logic response provided the potential to better
characterize the associations.
Our results indicate that short-term inhala-
tion exposures to CAPs can promote vasocon-
striction of small pulmonary arteries in normal
and CB rats, suggesting that the pulmonary
vasculature may be a target for the effects of
ambient particles. These morphologic ﬁndings
are in agreement with other morphologic stud-
ies of small pulmonary vessel injury in dogs
from areas of high ambient pollution in
Mexico City (51). Furthermore, because the
animals of the study reported here were sacri-
ﬁced using an overdose of pentobarbital anes-
thesia, it is possible that our morphometric
studies underestimate the magnitude of the
changes because it is known that pentobarbital
used as an anesthetic can attenuate vasocon-
striction (52,53). In addition, a number of
recent studies of pulmonary endothelium-
derived mediators responding to ambient par-
ticle exposures have been reported (54).
The most important regulator of pul-
monary vascular tone and blood flow is the
balance of vasoconstrictive and vasodilative
mediators. The endothelium-derived constrict-
ing factors include a family of three endothelin
isoforms (ET-1, ET-2, and ET-3) (55). These
effects are counterbalanced by the pulmonary
vascular endothelium’s ability to release
endothelium-derived relaxing factors (56),
which includes nitric oxide (NO) (57,58) and
prostacyclin (59). Increased plasma levels of
ET-1 were observed in rats after inhalation of
urban particles (60). Furthermore, human vol-
unteers exposed to urban particulate matter
<2 .5 µm in diameter (PM2.5) by inhalation
had increased ET-1 and ET-3 plasma concen-
trations (61). Cigarette smoke also increases
plasma ET-1 plasma levels (62). Whether
some bioavailable components of ambient par-
ticles induce lung vascular endothelial cells to
alter the release, turnover, or receptor activity
(regulation) of vascular mediators is unclear at
this time. Pulmonary endothelial dysfunction,
represented by an increase in vasoconstrictive
activity locally through an autocrine/paracrine
effect on the pulmonary vasculature, could
explain the observed vasoconstriction in our
study. Perhaps an endocrine effect at the level
of the coronary vasculature could lead to a
vasoconstrictive effect with enhanced ischemia
and predisposition to arrhythmias (63–66).
This attractive hypothesis could suggest a
plausible pathogenic pathway to the increased
morbidity and mortality associated with pre-
existing cardiovascular and respiratory diseases
observed in epidemiologic studies.
The pathologic mechanism by which par-
ticles result in pulmonary vasoconstriction
may be similar to that observed for other pul-
monary vasoconstrictors. For instance, the
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Table 4. Standardized correlation coefﬁcient estimates (SEs) and p-values from univariate linear regression
model analyses of log vascular L/W ratio and particle exposure parameters for the total group (normal plus
CB animals) and for normal and CB groups.
CAPs mass  Vanadium Silicon Lead Sulfate EC OC
Total –0.345 (0.140) –0.182 (0.128) –0.490 (0.136) –0.297 (0.134) –0.388 (0.136) –0.360 (0.135) –0.328 (0.135)
p = 0.0170* p = 0.1601 p = 0.0007* p = 0.0310* p = 0.0062* p = 0.0104* p = 0.0189*
Normal –0.281 (0.158) –0.155 (0.154) –0.441 (0.141) –0.203 (0.154) –0.313 (0.147) –0.277 (0.150) –0.210 (0.150)
p = 0.1019 p = 0.3189 p = 0.0031* p = 0.1937 p = 0.0308 p = 0.0723 p = 0.1689
CB –0.267 (0.149) –0.147 (0.145) –0.291 (0.144) –0.267 (0.149) –0.281 (0.150) –0.283 (0.149) –0.289 (0.145)
p = 0.0793 p = 0.3169 p = 0.0494* p = 0.0805 p = 0.0670 p = 0.0638 p = 0.0520*
*Signiﬁcant association. 
Figure 4. Dose–response relationship between log
L/W ratios and the 2-day mean silicon concentration
for both normal and CB rats.
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Normalmonocrotaline-induced model of pulmonary
vascular injury in rats is characterized by pro-
gressive pulmonary hypertension and
histopathologic lung alterations, including
progressive capillary endothelial cell damage,
medial thickening of smooth muscle layer of
small- and medium-sized pulmonary arteries,
and fragmentation of elastic laminae in main
pulmonary arteries. Our study shows thick-
ening of pulmonary arteries at the light
microscopic level. In the animal model of
monocrotaline-induced pulmonary hyperten-
sion (67,68), endothelial ET-1 production is
elevated and NO activity is decreased. The
fact that deaths occur in animals of this
model when exposed to particles raises the
possibility that the same mechanism involved
in response to monocrotaline is operative in
response to particle inhalation. In addition,
in the animal model of CB, the observed
vasoconstriction could be explained also by a
predominant action of endothelium-derived
constricting factors. Decreased NO activity
and increased plasma levels of ET-1 in
response to hypoxemia have been described
and also could explain the pulmonary arterial
vasoconstriction and pulmonary hyperten-
sion observed in COPD (56,69).
Thus, vasoconstriction of pulmonary ves-
sels associated with CAPs exposures may be
the result of an effect at the level of the pul-
monary vascular endothelial cells with an
abnormal balance between releasing of
endothelium-derived constricting factors and
endothelium-derived relaxing factors. We
speculate that the resultant pulmonary
endothelial dysfunction with predominant
release of mediators that constrict vessels
could lead to a dominant vasoconstrictive sta-
tus in the lungs and possibly in the heart.
These same mediators could potentiate
altered hemostasis with increased platelet acti-
vation and enhanced blood coagulability and
thrombogenesis. In animal studies, signiﬁcant
mortality associated with ambient or surro-
gate particle inhalation or intratracheal instil-
lation has been observed only in models
where there was a preexisting endothelial
injury. Human epidemiologic studies show
that the increased risk of death is greater in
people with COPD (3), a disease process that
includes some pulmonary endothelial dys-
function (69). Further studies of CAPs on the
pulmonary arterial vasculature are needed to
establish the full extent and the chronicity of
these demonstrated effects.
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